Impact Biomedical (IBO) Debt Ratio (2023 - 2025)
Impact Biomedical (IBO) posted Debt Ratio of 1.26 for Q3 2025, up 7.16% on a QoQ basis from 1.17 in Q2 2025, and up 636.16% year-over-year from 0.17 in Q3 2024.
Impact Biomedical (IBO) Debt Ratio (2023 - 2025) Analysis & Trends
Impact Biomedical's Debt Ratio history runs 3 years deep, the most recent figure standing at 1.26 for Q3 2025.
- Quarterly Debt Ratio rose 636.16% year-over-year to 1.26 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 1.26 (up 636.16% YoY) and the FY2024 annual result came in at 0.44, up 61.75% from the prior year.
- Debt Ratio was 1.26 for Q3 2025 at Impact Biomedical, up from 1.17 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.26 in Q3 2025 and bottomed at 0.17 in Q3 2024.
- A 3-year average of 0.63 and a median of 0.45 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2024 — Debt Ratio soared 61.75% — and 2025, when it jumped 636.16%.
- Impact Biomedical's Debt Ratio stood at 0.27 in 2023, then surged by 61.75% to 0.44 in 2024, then jumped by 187.2% to 1.26 in 2025.
- Business Quant data shows IBO's Debt Ratio at 1.26 in Q3 2025, 1.17 in Q2 2025, and 0.46 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.26 |
| Jun 30, 2025 | 1.17 |
| Mar 31, 2025 | 0.46 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.17 |
| Dec 31, 2023 | 0.27 |